More than 40,000 doses of Oxford\u2019s Ebola vaccine have been manufactured by Serum Institute of India (SII) in just 60 days and doses shipped to Uganda.
A study published in Nature by researchers from Washington University School of Medicine in St. Louis, Stanford University School of Medicine and Oxford University have developed a way to find the crucial protein fragment that drives autoimmunity, as well as the immune cells that respond to it.
The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.
Continual monitoring of genetic changes in parasite populations is a powerful tool for analysing malaria outbreaks and identifying emerging multidrug-resistant malaria strains, say researchers from NDM\u2019s Mahidol-Oxford Tropical Medicine Research Unit (MORU).
The study from the Worldwide Antimalarial Resistance Network (WWARN) provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.
The inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.
The Nuffield Department of Medicine and the University of Navarra have entered into a Memorandum of Understanding for collaboration on research and to apply new immunotherapy techniques to cancer patients.
The Leedham Lab at the Wellcome Centre for Human Genetics in the Nuffield Department of Medicine (NDM) has been awarded over \u00a32m from Cancer Research UK to develop a new tool that could help guide how bowel cancer patients are treated in the future.
A vaccine developed by the Oxford Vaccine Group\u2019s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from Nuffield Department of Medicine's Jenner Institute has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.
Researchers from the Nuffield Department of Medicine\u2019s Jenner Institute have today reported the findings from a study investigating whether previously identified correlates of protection associated with the risk of tuberculosis (TB) disease could also be associated with the risk of infection from the bacteria that causes TB.
A phase I/IIa clinical trial that the Nuffield Department of Medicine's Jenner Institute collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was temporarily withdrawn.
Established in 1998, the Academy of Medical Sciences is one of the four UK National Academies, coordinating scholarly research activities and standards in the UK.
The UK\u2019s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.
Health and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.
Researchers from the Nuffield Department of Medicine have today reported new findings from a study exploring how certain genes can help generate a strong immune response following vaccination with two commonly used COVID-19 vaccines \u2013 identifying a particular gene associated with a high antibody response.
Accepting its first students in in October 2023, the Postgraduate Diploma in Global Health Research is specifically targeted at researchers and clinicians in low income countries, and will offer accessibility never previously available.
A new study found viral monkeypox DNA on multiple surfaces, personal protective equipment, and in air samples in hospital isolation rooms. For some of the samples, the viral particles were capable of replicating and therefore could potentially infect other people.
A University of Oxford team has been awarded a grant to study one of the major unsolved questions about asthma \u2013 why women are more likely to have it than men and why they are twice as likely to die from it.
To investigate whether the symptoms of \u2018long-COVID\u2019 are associated with any long-term damage that reduces the function of the lungs and respiratory system, a study led by University of Oxford researchers used a novel computational approach to assess how COVID-19 may affect long-term lung function.
![\"\"](\"https://www.ndm.ox.ac.uk/news/oxford-ebola-vaccine-manufactured-and-shipped-in-record-time-by-sii/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n